Provided by Tiger Fintech (Singapore) Pte. Ltd.

AstraZeneca PLC

70.46
-1.3300-1.85%
Volume:4.09M
Turnover:287.60M
Market Cap:218.52B
PE:28.36
High:70.70
Open:70.08
Low:69.70
Close:71.79
Loading ...

STAAR Surgical Announces Changes to Board of Directors

Business Wire
·
25 Apr

Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?

Zacks
·
25 Apr

Unveiling Astrazeneca (AZN) Q1 Outlook: Wall Street Estimates for Key Metrics

Zacks
·
24 Apr

AstraZeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
24 Apr

AstraZeneca CEO Urges Europe to Spend More on Health or Risk Falling Behind -- Market Talk

Dow Jones
·
23 Apr

Astrazeneca (AZN) Rises But Trails Market: What Investors Should Know

Zacks
·
23 Apr

AstraZeneca PLC ADR Rises Tuesday, Still Underperforms Market

Dow Jones
·
23 Apr

AstraZeneca PLC Stock Falls Tuesday, Outperforms Market

Dow Jones
·
23 Apr

Market Chatter: Trump Administration Mulls Cutting US Drug Prices to International Levels

MT Newswires Live
·
22 Apr

Trump Mulls Cutting US Drug Prices to International Levels, Reuters Reports

MT Newswires Live
·
22 Apr

Hutchmed Completes Patient Enrollment in Phase II Gastric Cancer Trial in China

MT Newswires Live
·
22 Apr

Goldman Sachs Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
22 Apr

Cellectis SA (CLLS) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ...

GuruFocus.com
·
22 Apr

Should You Buy, Sell or Hold AstraZeneca Stock Before Q1 Earnings?

Zacks
·
21 Apr

AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients

Benzinga
·
21 Apr

AstraZeneca Says Breast Cancer Combination Therapy Shows Improvement in Progression-Free Survival

MT Newswires Live
·
21 Apr

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2+ metastatic breast cancer

Business Wire
·
21 Apr

AstraZeneca Slides Thursday, Underperforms Market

Dow Jones
·
18 Apr

Lilly's Weight-Loss Pill Shocks Wall Street

GuruFocus.com
·
17 Apr

AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day

Dow Jones
·
17 Apr